Fu Senmei: Net profit for the first quarter of 2026 was 387 million yuan, an increase of 161.99% year-on-year.

Fosun Pharma announced that its revenue for the first quarter of 2026 was 2.58 billion yuan, a year-on-year decrease of 21.75%; net profit was 387 million yuan, a year-on-year increase of 161.99%.